Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction
Clinical trial NCT07158606 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07158606
- Sponsor
- Versiti Blood Health
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2031-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.